Disease burden of multidrug-resistant tuberculosis in China and regions with different income levels in the world
10.3969/j.issn.1006-2483.2023.04.002
- VernacularTitle:中国与世界不同收入水平地区耐多药结核病疾病负担研究
- Author:
Jiachen WANG
1
;
Ruoyu XYU
1
;
Yuetong LIN
1
;
Xiang QU
1
;
Liqun YAO
1
;
Jianhua ZHANG
1
Author Information
1. Department of Health Statistics , School of Public Health , Weifang Medical University，Weifang , Shandong 261053 , China
- Publication Type:Journal Article
- Keywords:
MDR-TB;
Burden of disease;
Annual percent change (APC)
- From:
Journal of Public Health and Preventive Medicine
2023;34(4):7-10
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the disease burden of multidrug-resistant tuberculosis (MDR-TB) in China and regions with different income levels in the world from 1990 to 2019. Methods Using the Global Burden of Disease Study 2019 (GBD2019) results, the changes of the disease burden of MDR-TB in China and regions with different income levels in the world were described and analyzed using the Joinpoint Regression Program 4.8.0.1 software. Results From 1990 to 2019, the age standardized incidence, mortality and DALY rates in China and other areas with different income levels in the world basically showed a trend of first rising and then decreasing at the turning point of the late 20th century and early 21st century, except for low-income areas where the age standardized incidence rate showed an overall upward trend. In 2019, the incidence rate, mortality and DALY rate of MDR-TB in China were 9 times, 6.67 times and 6.89 times higher than those in high-income areas, respectively. The incidence rate in China was 6 times lower than that in low and middle-income areas, while the mortality and DALY rate in China were 26 times and 32.53 times lower than those in low-income areas, respectively. The age standardized incidence, mortality rate and DALY rate of MDR-TB in men were higher than those in women. Risk factors for the burden of MDR-TB disease included alcohol consumption, smoking, and high fasting blood glucose. Conclusion From 1990 to 2019, there are significant regional and gender differences in the disease burden of multidrug-resistant tuberculosis in China and regions with different income levels in the world. Multidrug-resistant tuberculosis is still a major challenge for tuberculosis control in the world. It is necessary to develop more effective control strategies and health care systems to deal with multidrug-resistant tuberculosis.
